The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
A golfing buddy of mine told me his son had recently bought 50,000 shares of a bioteck co and asked me to look at it for him. I rarely buy stocks under $ 10 and almost never one that dosn't pay at least a 4 % div. I suggested to my buddie that his son should have a winner and if he could afford a little risk he should jump on it also. I then bouhgt 5000 shrs and several options. Todays news granting "orphan status" from tha FDA intiated this post. If this drug comes anywhere near doing what their studies show, it couyld be a triple bagger very quickly. I bought between 6.00 and 6.30 it croosed 9.95 this am.
Might want to stick with those dividend stocks.